Aurora Cannabis (ACB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.99, -2.68% vs the prior close of $4.10.
- Volume 971.50K shares, 0.7x its 50-day average.
- New SEC filings: SC14D9F/A (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
ACB dips 2.7% to $3.99, 5 down days in a row. Closed at $3.99, -2.68% vs the prior close of $4.10. Day range $3.98–$4.12, opened at $4.11.
ACB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ACB dips 2.7% to $3.99, 5 down days in a row
- Closed at $3.99, -2.68% vs the prior close of $4.10. Day range $3.98–$4.12, opened at $4.11.
- Volume was 971.50K shares, 0.7x its 50-day average of 1.37M.
- Price is +0.8% vs its 50-day average ($3.96) and +12.3% vs its 200-day average ($3.55).
- 52-week range $2.56–$6.36; today's close sits at 38% of that range, 37.3% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — ACB dips 1.7% to $4.10, 4 down days in a row
- Closed at $4.10, -1.68% vs the prior close of $4.17. Day range $4.08–$4.22, opened at $4.15.
- Volume was 888.80K shares, 0.6x its 50-day average of 1.40M.
- Price is +4.1% vs its 50-day average ($3.94) and +15.3% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.36; today's close sits at 41% of that range, 35.5% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — ACB dips 2.8% to $4.17, 3 down days in a row
- Closed at $4.17, -2.80% vs the prior close of $4.29. Day range $4.13–$4.31, opened at $4.21.
- Volume was 1.19M shares, 0.8x its 50-day average of 1.41M.
- Price is +6.6% vs its 50-day average ($3.91) and +17.3% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.36; today's close sits at 42% of that range, 34.4% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 13, 2026 — ACB dips 1.4% to $4.29
- Closed at $4.29, -1.38% vs the prior close of $4.35. Day range $4.24–$4.34, opened at $4.25.
- Volume was 650.20K shares, 0.5x its 50-day average of 1.41M — lighter than usual.
- Price is +10.4% vs its 50-day average ($3.89) and +20.6% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.36; today's close sits at 46% of that range, 32.5% below the 52-week high.
Oct 12, 2026 — ACB slides 3.1% to $4.35
- Closed at $4.35, -3.12% vs the prior close of $4.49. Day range $4.29–$4.55, opened at $4.51.
- Volume was 603.90K shares, 0.4x its 50-day average of 1.42M — lighter than usual.
- Price is +12.8% vs its 50-day average ($3.86) and +22.2% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.36; today's close sits at 47% of that range, 31.6% below the 52-week high.
Oct 9, 2026 — ACB rises 1.4% to $4.49
- Closed at $4.49, +1.35% vs the prior close of $4.43. Day range $4.40–$4.57, opened at $4.41.
- Volume was 1.35M shares, 1.0x its 50-day average of 1.42M.
- Price is +17.4% vs its 50-day average ($3.83) and +26.1% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.66; today's close sits at 47% of that range, 32.6% below the 52-week high.
Oct 8, 2026 — ACB dips 0.7% to $4.43
- Closed at $4.43, -0.67% vs the prior close of $4.46. Day range $4.37–$4.50, opened at $4.45.
- Volume was 1.46M shares, 1.0x its 50-day average of 1.41M.
- Price is +16.8% vs its 50-day average ($3.79) and +24.4% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.66; today's close sits at 46% of that range, 33.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — ACB dips 2.8% to $4.46
- Closed at $4.46, -2.83% vs the prior close of $4.59. Day range $4.44–$4.67, opened at $4.59.
- Volume was 1.38M shares, 1.0x its 50-day average of 1.41M.
- Price is +18.7% vs its 50-day average ($3.76) and +25.1% vs its 200-day average ($3.56).
- 52-week range $2.56–$6.66; today's close sits at 46% of that range, 33.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 6, 2026 — ACB rises 2.9% to $4.59, a 6-month high, 3 up days in a row
- Closed at $4.59, +2.91% vs the prior close of $4.46. Day range $4.40–$4.64, opened at $4.58.
- Volume was 1.94M shares, 1.4x its 50-day average of 1.40M.
- Price is +23.3% vs its 50-day average ($3.72) and +28.6% vs its 200-day average ($3.57).
- 52-week range $2.56–$6.66; today's close sits at 49% of that range, 31.1% below the 52-week high.
- That makes 3 straight gains.
- SEC filings that day: 6-K.
Oct 5, 2026 — ACB jumps 13.8% to $4.46, a 6-month high on 3.5x normal volume
- Closed at $4.46, +13.78% vs the prior close of $3.92. Day range $4.30–$4.65, opened at $4.37.
- Volume was 4.63M shares, 3.5x its 50-day average of 1.33M — unusually heavy trading.
- Price is +21.0% vs its 50-day average ($3.69) and +24.8% vs its 200-day average ($3.57).
- 52-week range $2.56–$6.66; today's close sits at 46% of that range, 33.1% below the 52-week high.
Oct 2, 2026 — ACB rises 0.5% to $3.92
- Closed at $3.92, +0.51% vs the prior close of $3.90. Day range $3.87–$3.97, opened at $3.94.
- Volume was 682.00K shares, 0.5x its 50-day average of 1.33M — lighter than usual.
- Price is +7.4% vs its 50-day average ($3.65) and +9.5% vs its 200-day average ($3.58).
- 52-week range $2.56–$6.66; today's close sits at 33% of that range, 41.2% below the 52-week high.
ACB latest news & SEC filings
Every SEC filing by or about ACB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SC14D9F/A — SC14D9F/A filing
SC14D9F/A filing
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · Form SC14D9F/A — SC14D9F/A filing
SC14D9F/A filing
Oct 6, 2026 · Form SC14D9F/A — SC14D9F/A filing
SC14D9F/A filing
Oct 6, 2026 · Form SC14D1F/A — SC14D1F/A filing
SC14D1F/A filing
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form SC14D9F/A — SC14D9F/A filing
SC14D9F/A filing
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form SC14D9F/A — SC14D9F/A filing
SC14D9F/A filing
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade ACB
- How much it moves: over the last 20 sessions the average daily move was 2.64% (largest 13.8%).
- Liquidity: about 1.18M shares (≈$4.71M) trade per day on average.
- 52-week position: $3.99 vs a range of $2.56–$6.36 (38% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 14, 2026; 6-K Oct 8, 2026; 6-K Oct 7, 2026.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
ACB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.11 | 4.12 | 3.98 | 3.99 | 971.50K |
| Oct 15, 2026 | 4.15 | 4.22 | 4.08 | 4.10 | 888.80K |
| Oct 14, 2026 | 4.21 | 4.31 | 4.13 | 4.17 | 1.19M |
| Oct 13, 2026 | 4.25 | 4.34 | 4.24 | 4.29 | 650.20K |
| Oct 12, 2026 | 4.51 | 4.55 | 4.29 | 4.35 | 603.90K |
| Oct 9, 2026 | 4.41 | 4.57 | 4.40 | 4.49 | 1.35M |
| Oct 8, 2026 | 4.45 | 4.50 | 4.37 | 4.43 | 1.46M |
| Oct 7, 2026 | 4.59 | 4.67 | 4.44 | 4.46 | 1.38M |
| Oct 6, 2026 | 4.58 | 4.64 | 4.40 | 4.59 | 1.94M |
| Oct 5, 2026 | 4.37 | 4.65 | 4.30 | 4.46 | 4.63M |
| Oct 2, 2026 | 3.94 | 3.97 | 3.87 | 3.92 | 682.00K |
| Oct 1, 2026 | 3.87 | 3.95 | 3.85 | 3.90 | 607.10K |
| Sep 30, 2026 | 4.01 | 4.02 | 3.82 | 3.90 | 1.61M |
| Sep 29, 2026 | 4.08 | 4.09 | 4.02 | 4.03 | 224.90K |
| Sep 28, 2026 | 4.08 | 4.12 | 3.97 | 4.09 | 496.80K |
| Sep 25, 2026 | 4.13 | 4.16 | 4.08 | 4.10 | 684.70K |
| Sep 24, 2026 | 4.13 | 4.20 | 4.09 | 4.16 | 686.90K |
| Sep 23, 2026 | 4.26 | 4.30 | 4.18 | 4.22 | 1.35M |
| Sep 22, 2026 | 4.05 | 4.29 | 4.03 | 4.27 | 1.42M |
| Sep 21, 2026 | 3.88 | 4.05 | 3.87 | 4.03 | 809.00K |
About Aurora Cannabis
Aurora Cannabis (ACB) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in EDMONTON, Alberta, Canada. State of incorporation: British Columbia, Canada. Fiscal year ends March 31. SEC CIK 1683541.
ACB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ACB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ACB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ACB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.